125 Results for "

Tolerated

" in MedChemExpress (MCE) Product Catalog:
Products (125)

125 Results for "Tolerated" in MCE Product Catalog:

23
23 Publications Verification
Art. -Nr.: HY-164388
CAS. Nr.: 162852-62-2
Z-VAD is an irreversible, broad-spectrum pan-caspase inhibitor that can inhibit a variety of caspases including caspase-3, -6, -7, -8, -9, etc. (with a weaker inhibitory effect on caspase-2). Z-VAD can block apoptosis signaling pathways, induce autophagy and necrosis in tumor cells, and has anti-angiogenic activity. Z-VAD can enhance the sensitivity of breast cancer and lung cancer cells to radiotherapy in vitro and in vivo, and prolong the growth delay of tumor xenograft models. Z-VAD is well tolerated and is mainly used in research related to cancer radiosensitization and cell death pathway regulation .
loading...
    loading...
21
21 Cited Publications
Art. -Nr.: HY-B0265
CAS. Nr.: 66085-59-4
Synonyms: BAY-e 9736
Forschungsgebiete:  

Cardiovascular Disease Cancer

Nimodipine (BAY-e 9736) is an orally active, well-tolerated and light-sensitive dihydropyridine calcium antagonist. Nimodipine can be used for the research of cerebrovascular disorders .
loading...
    loading...
18
18 Cited Publications
Art. -Nr.: HY-B0193A
CAS. Nr.: 19237-84-4
Prazosin hydrochloride is a well-tolerated, CNS-active α1-adrenergic receptor antagonist for the research of high blood pressure and alcohol use disorders . Prazosin hydrochloride potently inhibits Norepinephrine (NE)-stimulated 45Ca efflux with an IC50 of 0.15 nM .Prazosin hydrochloride inhibits organic cation transporters OCT-1 and OCT-3 with IC50s of 1.8, and 13 μM, respectively .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-112163
CAS. Nr.: 2098191-53-6
Reinheit:  99.69%
Synonyms: eFT226
Zotatifin (eFT226) is a potent, selective, and well-tolerated eIF4A inhibitor. Zotatifin promotes eIF4A binding to specific mRNA sequences with recognition motifs in the 5’-UTRs (IC50=2 nM) and interferes with the assembly of the eIF4F initiation complex . Zotatifin shows robust antiviral effects, it effectively reduces viral infectivity by inhibiting SARS-CoV-2 NP protein biogenesis (IC90=37 nM) . Zotatifin induces cell apoptosis .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-101560
CAS. Nr.: 1923833-60-6
Reinheit:  99.81%
Synonyms: BMS-986205; ONO-7701
Forschungsgebiete:  

Cancer

Linrodostat (BMS-986205) is a selective and irreversible indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor with an IC50 value of 1.1 nM in IDO1-HEK293 cells. Linrodostat is well tolerated with potent pharmacodynamic activity in advanced cancers .
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-N1373
CAS. Nr.: 6882-68-4
Sophoridine is a quinolizidine alkaloid isolated from Leguminous plant Sophora flavescens. Sophoridine induces apoptosis. Sophoridine has the potential to be a novel, potent and selective antitumor agent candidate for pancreatic cancer with well-tolerated toxicity .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-145603
CAS. Nr.: 2374124-49-7
Reinheit:  98.19%
Synonyms: VX-121
Target:  

CFTR Chloride Channel

Forschungsgebiete:  

Neurological Disease

Vanzacaftor (VX-121) is an orally active noval corrector of Cystic fibrosis transmembrane conductance regulator (CFTR). Vanzacaftor improves processing and trafficking of CFTR protein as well as increases chloride transport in triple combined with Tezacaftor (HY-15448) and Deutivacaftor. Vanzacaftor-Tezacaftor-Deutivacaftor is safe and well tolerated, improving lung function, respiratory symptoms, and CFTR function with cystic fibrosis, which is promising for research in the field of cystic fibrosis diseases .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-100375
CAS. Nr.: 1577222-14-0
Reinheit:  99.90%
Synonyms: ALKS 8700; BIIB098
Target:  

Keap1-Nrf2

Forschungsgebiete:  

Inflammation/Immunology

Diroximel fumarate (ALKS 8700) is an orally-active and well-tolerated monomethyl fumarate (MMF) proagent in a controlled-release formulation. Diroximel fumarate is considered as active equivalent to its active metabolite dimethyl fumarate (DMF). Diroximel fumarate has a favorable safety and efficacy profile, has the potential for the study of multiple sclerosis (MS). Diroximel fumarate is a Nrf2 activator that alleviate MGO-induced pain hypersensitivity .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-10122
CAS. Nr.: 160970-54-7
Reinheit:  99.82%
Synonyms: KAD 3213; KMD 3213
Forschungsgebiete:  

Endocrinology Cancer

Silodosin (KAD 3213; KMD 3213) is a potent, selective and orally active α1A-adrenergic receptor (α1A-AR) blocker. Silodosin exhibits high affinity for α1A-AR (Ki=0.036 nM), over 162-fold and 50-fold than for α1B-AR and α1D-AR with Ki values of 21 nM and 2.0 nM, respectively. Silodosin is an effective and well-tolerated agent, it can be used for the investigation of LUTS/BPH .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-12170
CAS. Nr.: 192329-42-3
Reinheit:  99.27%
Synonyms: AG3340; KB-R9896
Target:  

MMP Apoptosis

Forschungsgebiete:  

Cancer

Prinomastat (AG3340) is a broad spectrum, potent, orally active metalloproteinase (MMP) inhibitor with IC50s of 79, 6.3 and 5.0 nM for MMP-1, MMP-3 and MMP-9, respectively. Prinomastat inhibits MMP-2, MMP-3, MMP-13 and MMP-9 with Kis of 0.05 nM, 0.3 nM, 0.03 nM and 0.26 nM, respectively. Prinomastat crosses blood-brain barrier. Antitumor avtivity .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-12170A
CAS. Nr.: 1435779-45-5
Reinheit:  98.18%
Synonyms: AG3340 hydrochloride; KB-R9896 hydrochloride
Target:  

MMP Apoptosis

Forschungsgebiete:  

Cancer

Prinomastat hydrochloride (AG3340 hydrochloride) is a broad spectrum, potent, orally active metalloproteinase (MMP) inhibitor with IC50s of 79, 6.3 and 5.0 nM for MMP-1, MMP-3 and MMP-9, respectively. Prinomastat hydrochloride inhibits MMP-2, MMP-3, MMP-13 and MMP-9 with Kis of 0.05 nM, 0.3 nM, 0.03 nM and 0.26 nM, respectively. Prinomastat hydrochloride can cross blood-brain barrier. Antitumor avtivity .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-153268
CAS. Nr.: 2607829-38-7
Reinheit:  99.03%
Synonyms: BDTX-1535; EGFR-IN-76
Target:  

EGFR

Silevertinib (BDTX-1535) is an irreversible, brain-penetrant, selective and orally active EGFR inhibitor with wild-type EGFR-sparing. Silevertinib targets key EGFR resistance mutations, including the kinase domain (C797S, L718Q, G724S, S768I), extracellular domain (EGFRvIII, A289X), and EGFR amplification. Silevertinib exerts anti-tumor activity with well tolerated in vivo. Silevertinib can be used for non-small cell lung cancer (NSCLC) and glioblastoma (GBM) research .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-156654
CAS. Nr.: 2755812-39-4
Reinheit:  99.90%
Synonyms: PF-07817883
Target:  

SARS-CoV Virus Protease

Forschungsgebiete:  

Infection

Ibuzatrelvir (PF-07817883), a second-generation, orally bioavailable, is SARS-CoV-2 main protease (M pro and 3CL pro) inhibitor with improved metabolic stability. Ibuzatrelvir has demonstrated pan-human coronavirus antiviral activity and off-target selectivity profile in vitro and in preclinical animal studies. Ibuzatrelvir is well tolerated with a safety profile similar to placebo and prevents viral infection and transmission. Ibuzatrelvir can be used to inhibit COVID-19 .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-109523
CAS. Nr.: 143201-11-0
Reinheit:  99.84%
Cerivastatin sodium is a synthetic lipid-lowering agent and a highly potent, well-tolerated and orally active HMG-CoA reductase inhibitor, with a Ki of 1.3 nM/L. Cerivastatin sodium reduces low-density lipoprotein cholesterol levels. Cerivastatin sodium also inhibits proliferation and invasiveness of MDA-MB-231 cells, mainly by RhoA inhibition, and has anti-cancer effect .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-16712
CAS. Nr.: 1627503-67-6
Target:  

TGF-β Receptor

Forschungsgebiete:  

Cancer

LDN-214117 is an orally active ALK2 inhibitor with well-tolerated and good brain penetration. LDN-214117 has a high selectivity and low cytotoxicity for ALK2 with an IC50 value of 24 nM. LDN-214117 also is a specific bone morphogenetic proteins (BMPs) signaling inhibitor and has relatively selective inhibition for BMP6 with an IC50 value of 100 nM. LDN-214117 can be used for the research of fibrodysplasia ossificans progressiva (FOP), diffuse intrinsic pontine glioma (DIPG) .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-16976
CAS. Nr.: 1428569-85-0
Target:  

Pim

Forschungsgebiete:  

Cancer

GDC-0339 is a potent, orally bioavailable and well tolerated pan-Pim kinase inhibitor, with Kis of 0.03 nM, 0.1 nM and 0.02 nM for Pim1, Pim2 and Pim3, respectively. GDC-0339 is discovered as a potential treatment of multiple myeloma .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-122611A
CAS. Nr.: 1353749-74-2
Reinheit:  99.97%
Forschungsgebiete:  

Cancer

CSRM617 hydrochloride is a selective small-molecule inhibitor of the transcription factor ONECUT2 (OC2, a master regulator of androgen receptor) with a Kd of 7.43 uM in SPR assays, binding to OC2-HOX domain directly. CSRM617 hydrochloride induces apoptosis by appearance of cleaved Caspase-3 and PARP. CSRM617 hydrochloride is well tolerated in the prostate cancer mouse model
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-109052
CAS. Nr.: 1200493-78-2
Reinheit:  99.77%
Synonyms: JNJ-54861911
Target:  

Beta-secretase

Forschungsgebiete:  

Neurological Disease

Atabecestat (JNJ-54861911) is a potent brain-penetrant and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, achieves robust and high CSF Aβ reduction. Atabecestat s tolerated and displays a sustained pharmacokinetic (PK) and pharmacodynamic (PD) characteristics. Atabecestat has the potential for Alzheimer's Disease treatment .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-129650
CAS. Nr.: 938435-69-9
Reinheit:  99.08%
Synonyms: AV-45; Flobetapir
Forschungsgebiete:  

Others

Flobetapir (AV-45) may be a well-tolerated imaging agent. Flobetapir synthesizes Florbetapir (18F) that is a PET scanning radiopharmaceutical compound containing the radionuclide fluorine-18 .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P1682
CAS. Nr.: 1051366-32-5
Synonyms: POL6326
Target:  

CXCR Arrestin

Forschungsgebiete:  

Cancer

Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide blocks β-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects .
loading...
    loading...